Letter: Clutter Unclogs NSF

Kudos to Mary Clutter and advisers who are responsible for NSF's new policy on grant proposal format ("NSF Stresses Publication Quality, Education With New Grant Format," The Scientist, Dec. 11, 1989, page 2). By limiting biographical sketches to 10 publications, NSF joins Harvard Medical School in spotlighting quality rather than quantity as the principal determinant of an investi-gator's performance. By requiring investigators to include statements about the educational and training value of

Written byWilliam Cooper
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Kudos to Mary Clutter and advisers who are responsible for NSF's new policy on grant proposal format ("NSF Stresses Publication Quality, Education With New Grant Format," The Scientist, Dec. 11, 1989, page 2). By limiting biographical sketches to 10 publications, NSF joins Harvard Medical School in spotlighting quality rather than quantity as the principal determinant of an investi-gator's performance. By requiring investigators to include statements about the educational and training value of proposed research, as well as documentation of previous training supervision, NSF leads a chorus of government and academic voices that have called for the provision of more incentives for training in scientific research at all educational levels in the university. If the steps taken by NSF to enlarge the educational pipeline and to foster high quality research stimulate more widespread changes in the system of incentives and rewards adopted by the government and academic institutions, we can begin ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies